Guidelines on the diagnosis and treatment of foot infection in persons with diabetes (IWGDF 2019 update)
- PMID: 32176444
- DOI: 10.1002/dmrr.3280
Guidelines on the diagnosis and treatment of foot infection in persons with diabetes (IWGDF 2019 update)
Abstract
The International Working Group on the Diabetic Foot (IWGDF) has published evidence-based guidelines on the prevention and management of diabetic foot disease since 1999. This guideline is on the diagnosis and treatment of foot infection in persons with diabetes and updates the 2015 IWGDF infection guideline. On the basis of patient, intervention, comparison, outcomes (PICOs) developed by the infection committee, in conjunction with internal and external reviewers and consultants, and on systematic reviews the committee conducted on the diagnosis of infection (new) and treatment of infection (updated from 2015), we offer 27 recommendations. These cover various aspects of diagnosing soft tissue and bone infection, including the classification scheme for diagnosing infection and its severity. Of note, we have updated this scheme for the first time since we developed it 15 years ago. We also review the microbiology of diabetic foot infections, including how to collect samples and to process them to identify causative pathogens. Finally, we discuss the approach to treating diabetic foot infections, including selecting appropriate empiric and definitive antimicrobial therapy for soft tissue and for bone infections, when and how to approach surgical treatment, and which adjunctive treatments we think are or are not useful for the infectious aspects of diabetic foot problems. For this version of the guideline, we also updated four tables and one figure from the 2016 guideline. We think that following the principles of diagnosing and treating diabetic foot infections outlined in this guideline can help clinicians to provide better care for these patients.
Keywords: diabetic foot; diagnosis; foot ulcer; guidelines; infection; microbiology; osteomyelitis.
© 2020 John Wiley & Sons Ltd.
Similar articles
-
Guidelines on the prevention of foot ulcers in persons with diabetes (IWGDF 2019 update).Diabetes Metab Res Rev. 2020 Mar;36 Suppl 1:e3269. doi: 10.1002/dmrr.3269. Diabetes Metab Res Rev. 2020. PMID: 32176451
-
Standards for the development and methodology of the 2019 International Working Group on the Diabetic Foot guidelines.Diabetes Metab Res Rev. 2020 Mar;36 Suppl 1:e3267. doi: 10.1002/dmrr.3267. Epub 2020 Jan 9. Diabetes Metab Res Rev. 2020. PMID: 31916377
-
Guidelines on offloading foot ulcers in persons with diabetes (IWGDF 2019 update).Diabetes Metab Res Rev. 2020 Mar;36 Suppl 1:e3274. doi: 10.1002/dmrr.3274. Diabetes Metab Res Rev. 2020. PMID: 32176441
-
IWGDF/IDSA guidelines on the diagnosis and treatment of diabetes-related foot infections (IWGDF/IDSA 2023).Diabetes Metab Res Rev. 2024 Mar;40(3):e3687. doi: 10.1002/dmrr.3687. Epub 2023 Oct 1. Diabetes Metab Res Rev. 2024. PMID: 37779323 Review.
-
Guidelines on use of interventions to enhance healing of chronic foot ulcers in diabetes (IWGDF 2019 update).Diabetes Metab Res Rev. 2020 Mar;36 Suppl 1:e3283. doi: 10.1002/dmrr.3283. Diabetes Metab Res Rev. 2020. PMID: 32176450 Review.
Cited by
-
Evaluation of empirical antibiotic use in diabetic foot infections at a tertiary hospital in Vietnam: A retrospective study.Medicine (Baltimore). 2024 Nov 15;103(46):e40597. doi: 10.1097/MD.0000000000040597. Medicine (Baltimore). 2024. PMID: 39560569 Free PMC article.
-
Personalized and predictive strategies for diabetic foot ulcer prevention and therapeutic management: potential improvements through introducing Artificial Intelligence and wearable technology.Med Pharm Rep. 2024 Oct;97(4):419-428. doi: 10.15386/mpr-2818. Epub 2024 Oct 30. Med Pharm Rep. 2024. PMID: 39502767 Free PMC article. Review.
-
Does complete resection of infected bone improve clinical outcomes in patients with diabetic foot osteomyelitis?Int Wound J. 2024 Oct;21(10):e70072. doi: 10.1111/iwj.70072. Int Wound J. 2024. PMID: 39375181 Free PMC article.
-
Widespread non-adherence to guidelines in the operative management of diabetes-related foot disease complications.Br J Surg. 2024 Oct 1;111(10):znae231. doi: 10.1093/bjs/znae231. Br J Surg. 2024. PMID: 39361151 Free PMC article. No abstract available.
-
Antibiotic Resistance Profiles of Extended-Spectrum β-Lactamase (ESBL)- and Metallo-β-Lactamase (MBL)-Producing Klebsiella pneumoniae Isolates From Diabetic Foot Ulcers: Implications for Treatment Strategies.Cureus. 2024 Aug 3;16(8):e66089. doi: 10.7759/cureus.66089. eCollection 2024 Aug. Cureus. 2024. PMID: 39229443 Free PMC article.
References
REFERENCES
-
- International Diabetes Federation. Diabetes Atlas, 8th edition, http://www.diabetesatlas.org/. 2019.
-
- Raspovic KM, Wukich DK. Self-reported quality of life and diabetic foot infections. J Foot Ankle Surg. 2014;53:716-719.
-
- Peters EJ, Childs MR, Wunderlich RP, Harkless LB, Armstrong DG, Lavery LA. Functional status of persons with diabetes-related lower-extremity amputations. Diabetes Care. 2001;24:1799-1804.
-
- Lavery LA, Armstrong DG, Murdoch DP, Peters EJ, Lipsky BA. Validation of the Infectious Diseases Society of America's diabetic foot infection classification system. Clin Infect Dis. 2007;44:562-565.
-
- Ndosi M, Wright-Hughes A, Brown S, et al. Prognosis of the infected diabetic foot ulcer: a 12-month prospective observational study. Diabet Med. 2018;35:78-88.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
